Related Experiment Videos
Mutant p53 proteins bind DNA abnormally in vitro
S E Kern1, K W Kinzler, S J Baker
1Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231.
Abstract:
The p53 gene encodes a phosphoprotein which binds DNA. Many types of tumors contain mutant p53 genes, but the effects of these mutations on the intrinsic properties of p53 are largely unknown. In the present study, we tested the effect of p53 mutations on DNA-binding. Each of 15 different mutant p53 gene products derived from human tumors or mouse transformants bound calf thymus DNA more weakly than did wild-type products. A significant subset of mutant proteins were also found to be underphosphorylated compared to the wild-type protein when produced in a reticulocyte lysate system, but this did not appear to explain the pattern of alterations of DNA-binding. The tested mutations were dispersed over several regions of the p53 gene and included representatives of all four of the evolutionarily conserved domains that are the known 'hot spots' for p53 mutation. The results suggest common pathways by which these various mutations affect the normal function of p53.
Insights
Mutant p53 proteins from tumors bind DNA less effectively than normal p53. These mutations, found in key gene regions, impair p53
Area of Science:
- Molecular Biology
- Cancer Genetics
- Protein Biochemistry
Background:
- The p53 gene encodes a DNA-binding phosphoprotein crucial for cellular regulation.
- Mutations in the p53 gene are prevalent in various human tumors.
- The functional impact of p53 mutations on its intrinsic properties, particularly DNA-binding, remains largely uncharacterized.
Purpose of the Study:
- To investigate the effects of diverse p53 mutations on the DNA-binding capabilities of the p53 protein.
- To correlate mutation location within the p53 gene with alterations in DNA-binding affinity.
Main Methods:
- Production of 15 distinct mutant p53 gene products from human tumors and mouse transformants.
- Assessment of DNA-binding affinity of mutant p53 proteins to calf thymus DNA using biochemical assays.
- Analysis of protein phosphorylation status in a reticulocyte lysate system.
Main Results:
- All 15 tested mutant p53 proteins exhibited weaker binding to DNA compared to wild-type p53.
- A subset of mutant p53 proteins showed reduced phosphorylation, but this did not fully explain the diminished DNA-binding.
- Mutations were located across multiple p53 gene regions, including evolutionarily conserved 'hot spots'.
Conclusions:
- p53 mutations commonly found in tumors significantly impair the protein's ability to bind DNA.
- These findings suggest convergent mechanisms by which diverse p53 mutations compromise its normal function.
- Understanding these mechanisms is critical for comprehending tumor development and exploring therapeutic strategies.